Dylan Dupuis

Stock Analyst at Roth MKM

(2.65)
# 1,908
Out of 4,814 analysts
9
Total ratings
44.44%
Success rate
33.17%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Dylan Dupuis

Chemomab Therapeutics
Dec 19, 2023
Reinstates: Buy
Price Target: $7
Current: $1.17
Upside: +498.29%
Inventiva
Sep 21, 2023
Reiterates: Buy
Price Target: $11
Current: $3.61
Upside: +204.71%
Terns Pharmaceuticals
Aug 8, 2023
Reiterates: Buy
Price Target: $23
Current: $2.72
Upside: +745.59%
Viking Therapeutics
May 31, 2023
Assumes: Buy
Price Target: $32
Current: $23.72
Upside: +34.91%
Unity Biotechnology
May 31, 2023
Initiates: Buy
Price Target: $10
Current: $0.92
Upside: +986.84%